Radioimmunotherapy of B-cell non-Hodgkin's lymphoma (original) (raw)

Nuclear Medicine Communications, 2009

View PDFchevron_right

Radioimmunotherapy of Lymphoma: A Treatment Approach Ahead of Its Time or Past Its Sell-By Date?

Tim Illidge

Journal of Clinical Oncology, 2010

View PDFchevron_right

Radioimmunotherapy of Relapsed Non-Hodgkin's Lymphoma with Zevalin, a 9~ Anti-CD20 Monoclonal Antibody 1

John Gutheil

1999

View PDFchevron_right

Radioimmunotherapy for Non-Hodgkin's Lymphoma

Gamal Akabani

Clinical Medicine & Research, 2005

View PDFchevron_right

The status of radioimmunotherapy in CD20+ non-Hodgkin's lymphoma

Terrence J Piva, Peter Eu

Targeted oncology, 2015

View PDFchevron_right

Pretargeted Radioimmunotherapy for B-Cell Lymphomas

D Scott Wilbur

Clinical Cancer Research, 2007

View PDFchevron_right

Radiolabeled antibody therapy in non-Hodgkins lymphoma: radiation protection, isotope comparisons and quality of life issues

James Murray

Cancer Treatment Reviews, 2004

View PDFchevron_right

Monoclonal Antibodies for Non-Hodgkin's Lymphoma: State of the Art and Perspectives

V. Augusti, Federico Carbone

Clinical and Developmental Immunology, 2010

View PDFchevron_right

Practical and clinical benefits of radioimmunotherapy lead to advantages in cost-effectiveness in the treatment of patients with non-Hodgkin??s lymphoma

Andreas Otte

Nuclear Medicine Communications, 2006

View PDFchevron_right

A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations

D. Wilbur

Blood, 2009

View PDFchevron_right

Pretargeted Versus Directly Targeted Radioimmunotherapy Combined with Anti-CD20 Antibody Consolidation Therapy of Non-Hodgkin Lymphoma

Edmund Rossi

Journal of Nuclear Medicine, 2009

View PDFchevron_right

Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma

Nabil Hanna

2000

View PDFchevron_right

Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas

D Scott Wilbur

2002

View PDFchevron_right

Radioimmunotherapy: Strategies for the future in indolent and aggressive lymphoma

Tim Illidge

Current Oncology Reports, 2009

View PDFchevron_right

Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma

Christine White

Seminars in Oncology, 2002

View PDFchevron_right

Development of DOTA-Rituximab to be Labeled with 90Y for Radioimmunotherapy of B-cell Non-Hodgkin Lymphoma

Samira Rasaneh

Iranian Journal of Pharmaceutical Research : IJPR, 2017

View PDFchevron_right

Radioimmunotherapy for lymphoma - analysis of clinical trials and treatment algorithms

Agnieszka Giza

Nuclear medicine review. Central & Eastern Europe, 2007

View PDFchevron_right

Radioimmunotherapy of relapsed or refractory non-Hodgkin's lymphoma (NHL) with IDEC-Y2B8

John Gutheil

International Journal of Radiation Oncology*Biology*Physics, 1998

View PDFchevron_right

Dose-Fractionated Radioimmunotherapy in Non-Hodgkin's Lymphoma Using DOTA-Conjugated, 90Y-Radiolabeled, Humanized Anti-CD22 Monoclonal Antibody, Epratuzumab

Eva Cavallin-ståhl

Clinical Cancer Research, 2005

View PDFchevron_right

Pubblicazione 11 Targeting B-cell non Hodgkin lymphoma New and old tricks

Antonio Giovanni Solimando

View PDFchevron_right

Antibody Therapy in Aggressive Lymphomas

Thomas Habermann

Hematology, 2007

View PDFchevron_right

Radioimmunotherapy: from current clinical success to future industrial breakthrough?

Jacques Barbet

Journal of Nuclear Medicine, 2015

View PDFchevron_right

Comparative biodistributions of pretargeted radioimmunoconjugates targeting CD20, CD22, and DR molecules on human B-cell lymphomas

D Scott Wilbur

Blood, 2007

View PDFchevron_right

A review of monoclonal antibody therapies in lymphoma

Yveline Chew

Critical Reviews in Oncology/Hematology, 2016

View PDFchevron_right

Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma

Michael L Goris

Clinical cancer research : an official journal of the American Association for Cancer Research, 1996

View PDFchevron_right

Microscopic Intratumoral Dosimetry of Radiolabeled Antibodies Is a Critical Determinant of Successful Radioimmunotherapy in B-Cell Lymphoma

Tim Illidge

Cancer Research, 2007

View PDFchevron_right

Evaluation of CD20, CD22, and HLA-DR Targeting for Radioimmunotherapy of B-Cell Lymphomas

D Scott Wilbur

Cancer Research, 2007

View PDFchevron_right

Monoclonal antibody therapy for classical Hodgkin lymphoma

Jan Walewski

Clinical Investigation, 2013

View PDFchevron_right

Radioimmunotherapy of B-cell non-Hodgkin's lymphoma (original) (raw)

Related papers